Page last updated: 2024-10-21

3-methylcholanthrene and Fibrocystic Breast Disease

3-methylcholanthrene has been researched along with Fibrocystic Breast Disease in 2 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Fibrocystic Breast Disease: A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gruenstein, M1
Meranze, DR1
Thatcher, D1
Shimkin, MB1
London, RS1
Murphy, L1
Kitlowski, KE1

Other Studies

2 other studies available for 3-methylcholanthrene and Fibrocystic Breast Disease

ArticleYear
Carcinogenic effects of intragastric 3-methylcholanthrene and 7,12-dimethylbenz[a]anthracene in Wistar and Sprague-Dawley rats.
    Journal of the National Cancer Institute, 1966, Volume: 36, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Female; Fibroadenoma; Fibrocystic Breast Dis

1966
Breast cancer prevention by supplemental vitamin E.
    Journal of the American College of Nutrition, 1985, Volume: 4, Issue:5

    Topics: Breast Neoplasms; Disease Models, Animal; Female; Fibrocystic Breast Disease; Food, Fortified; Human

1985